Skip to main content

Identification of Obesity and Tobacco Use in Claims Compared to Electronic Health Record (EHR) Data

Basic Details
Date
Type
Presentation
Description

​​​​​​This poster examines claims and electronic health record based indicators of obesity and tobacco use among sodium-glucose co-transporter-2 inhibitor (SGLT-2i) users in the FDA Sentinel System. It was presented at the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management. 

Materials

Identification of Obesity and Tobacco Use in Claims Compared to Electronic Health Record (EHR) Data

Information
Host

International Society for Pharmacoepidemiology

Related Assessment(s)
Sentinel Drug Study: Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors & Cohort Characterization
Presenter(s)

Casie Horgan, Po-Yin Chang, Meg Her, Rebecca Hawrusik, Alexander Peters, Catherine Corey, David J. Graham, Judith C. Maro and Noelle M. Cocoros